ArticleBMC infectious diseases2026

Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain.

Miquel Micó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.